T2I
NVO

Turim 21 Investimentos’s Novo Nordisk NVO Stock Holding History

Turim 21 Investimentos’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.24K Hold
151
– – ﹤0.01% 102
2026
Q1 		$5.55K Buy
+151
New +$7.16K ﹤0.01% 103

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Turim 21 Investimentos's NVO Position: Q2 2026 in Review

Turim 21 Investimentos held its Novo Nordisk (NVO) position steady in Q2 2026 at 151 shares worth $7.24K. The position accounts for ﹤0.01% of the portfolio, ranked #102.

Turim 21 Investimentos first reported a position in NVO in Q1 2026 and has held it in 2 quarters since. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Turim 21 Investimentos held 151 shares of Novo Nordisk worth $7.24K as of Q2 2026.
  • Turim 21 Investimentos left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Turim 21 Investimentos's portfolio in Q2 2026, its #102 holding.
  • Turim 21 Investimentos first reported a position in Novo Nordisk in Q1 2026 and has held it in 2 quarters since.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Turim 21 Investimentos's 13F filing for Q2 2026, filed 10 Aug 2026.